InvestorsHub Logo
Followers 44
Posts 2710
Boards Moderated 0
Alias Born 03/11/2014

Re: mazennnn post# 2119

Friday, 12/04/2020 12:22:07 AM

Friday, December 04, 2020 12:22:07 AM

Post# of 20519
way beyond $0.1...
Smart money loading, as $$$ p.p.s.written all over it and Todos Medical will be on NASDAQ OR NYSE late 2021, here is why:
DEC/1/2020
Todos recently completed the installation of two (2) Tecan® liquid handlers at its largest lab client in Wisconsin... Additionally, we are preparing to complete the installation of a similar lab automation workflow process at another lab in Brooklyn, NY in the month of December...
https://www.otcmarkets.com/stock/TOMDF/news/Todos-Medical-Provides-Strategic-Outlook?id=282044

DEC/2/2020
$3.2 million in sales for the month of November 2020  at Todos’ Wisconsin COVID-19 testing lab client...the Company was cash flow positive in November 2020 for its COVID-19 testing business, and has secured $2 million...
as a second potentially large COVID-19 testing client located in Brooklyn NY completes the installation of liquid handling automation technology that will allow it to achieve testing capacities of up to 20,000 PCR tests per day and begins placing reagents orders.
https://www.otcmarkets.com/stock/TOMDF/news/Todos-Medical-Announces-32-Million-in-Sales-for-November-2020-a-269-Increase-Sequential-Month-over-Month-Sales-Growth-fr?id=282126

Todos expects revenue growth for December 2020, as daily testing volumes for the majority of its COVID-19 testing clients increases sequentially on a weekly basis.

"We intend to focus our pipeline initially on breast cancer where we are building up significant intellectual property around our proprietary TBIA/FTIR platform, and commercial infrastructure by way of the strategic acquisition of Provista Diagnostics, so that we can consolidate our commercial opportunity and optimize assay performance as we go to market in 2021 in breast cancer blood testing".

291M O/S - DO THE MATH...